Click here to create your personal news page. The news that appears on Johnson and Johnson will appear there and be constantly updated. You can then modify the page, share it with your friends, or export it and have it appear elsewhere.

You can also create a personal news page and follow the news that interests you by clicking on the tab labelled 'New page'.
 

topics : related - allExplore

Wikio Shopping

  1. 1. Baby & Nursery
  2. 2. Car/Motor Bike
  3. 3. Communication
  4. 4. Computers
  5. 5. Electronics
  6. 6. Entertainment
  7. 7. Fashion & Lingerie
  8. 8. Finance
  9. 9. Gifts & Gadgets
  10. 10. Health & Beauty
  11. 11. Home & Garden
  12. 12. Household Appliances
  13. 13. Sport & Fitness
  14. 14. Travel
  15. 15. Video Games

New products

  1. 1. Western Digital ShareSpace 4TB
  2. 2. Sapphire Radeon HD 4550
  3. 3. LG KP500
  4. 4. Dell S2309W
  5. 5. Samsung Pixon
  6. 6. Shuttle D 1000H
  7. 7. Philips M200
  8. go to Shopping

Participate



Johnson and Johnson


Sort by : relevance - date - popularity
+Vote!

Sheri McCoy Made Worldwide Chairman, Pharmaceuticals Group at Johnson & Johnson

Johnson & Johnson, a New Jersey company, appointed Sheri McCoy Worldwide Chairman of their Pharmaceuticals Group. Sheri, whose promotion was reported in local news & newspapers, had been Worldwide Chairman of their Surgical Care Group. Read about it in the...

+Vote!

Four Value Priced Stocks: Sysco, Eli Lilly, PepsiCo and Johnson & Johnson

Dividends4Life submits: Recent gyrations in the market have caused more than one investor some heartburn. Each day I hear disgruntled comments due to losses and see many people looking for an out. Ryan Detrick, senior technical strategist at Schaeffer's Investment Research said: Complete Story ยป

+Vote!

MBF Financial: Analyst Reports for ConocoPhillips, Ford Motor Company, Banco Bradesco S.A. and Johnson & Johnson

LONDON (MARKET WIRE) MaybachFinancial.com is one of the fastest growing independent and unbiased research firms in the world. Through our numerous partnerships with many of the top investment minds in the world, we provide research on companies making a move in the markets. Investors seeking genuine analyst opinions on their investments for ConocoPhillips (NYSE: COP), Ford Motor Company (NYSE: F),...

+Vote!

Health Winners & Losers: Johnson & Johnson

The company announced a favorable ruling in its patent case against Boston Scientific.

+Vote!

Johnson & Johnson Share Exchange Offer

ZURICH, Switzerland, October 1 /PRNewswire-FirstCall/ -- - Share Exchange Offer to the Holders of the Following Securities - Shares of Johnson & Johnson - ISIN: US4781601046 - Symbol: JNJ The K&N Value Select Corporation offers the holders of the securities named above for every 1 Johnson & Johnson share a change into 1 share of K&N Value Select Corp. - ISIN: CH0006603085 - Symbol: KN4 . The...

+Vote!

Johnson & Johnson wins patent suit

Johnson & Johnson said a U.S. judge has awarded the company $1.2 billion in an 11-year patent battle with Medtronic Inc. and Boston Scientific Corp. over devices that prop open heart arteries after they're cleared of fat.

+Vote!

Advinus, Ortho-McNeil in drug discovery tie-up

Advinus Therapeutics, a company owned by the Tata group, has entered into a drug discovery and development collaboration with the US-based Ortho-McNeil-Janssen Pharmaceuticals Inc, a part of Johnson & Johnson, to develop two drug candidates for various disease targets.

+Vote!

Advinus strikes multmillion-dollar deals

India's Advinus Therapeutics announced a drug discovery and development collaboration with Johnson & Johnson's Ortho-McNeil-Janssen Pharmaceuticals. In the deal, Advinus will be responsible for drug discovery and early clinical development--until the completion of Phase IIa studies--while OMPJI will have an option to advance the drug candidates into late stage clinical trials and will be responsible...

+Vote!

Please, Housewives, No Diving in the Fountain of Youth

For Johnson & Johnson's Aveeno label, Ogilvy commissioned a street artist to create a three-dimensional "fountain of youth" with chalk on pavement.

+Vote!

Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc. Reintroduces LISTERINE(R) AGENT COOL BLUE(R) Tinting Rinse

Reformulated Pre-Brush Rinse Helps Kids Brush Better for Cleaner, Brighter Smiles MORRIS PLAINS, N.J., Sept. 29 /PRNewswire/ -- The leader in the adult and children's mouthwash category, Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc. introduces the new LISTERINE(R) AGENT COOL BLUE(R), a pre-brush mouthrinse that helps children, ages six and older, brush better for a cleaner, brighter...

+Vote!

FDA Questions Deaths in Anemia Drug Study

Federal health officials said that they were reviewing a higher rate of deaths among patients treated with a Johnson & Johnson anemia drug in a study of stroke patients. Sixteen percent of patients who were treated with the drug, Eprex, had died three months after the study began, compared with 9 percent who were given a placebo, the FDA said in a statement. The study was testing whether Eprex could...

+Vote!

Stock picks and pans for troubled times: Buy Johnson & Johnson, Monsanto, JPMorgan and closed-end funds

Filed under: Apple Inc (AAPL) , General Electric (GE) , General Motors (GM) , Johnson and Johnson (JNJ) , JPMorgan Chase (JPM) , Krispy Kreme Doughnuts (KKD) , Bank of America (BAC) , Boeing Co (BA) , Circuit City Stores (CC) , Wells Fargo (WFC) , Stocks to Buy , Stocks to Sell Another volatile week had passed over Wall Street, but by the end of it investors started breathing a sigh of relief in anticipation...

+Vote!

[Dumbass] "Band-aid" rapist gets 11 years of Johnson & Johnson & Johnson & Johnson & Johnson

2008-09-18 11:25:57 PM Bravo subby +1 2008-09-18 11:31:32 PM Indeed. +1 2008-09-18 11:36:13 PM Thirded+1 2008-09-18 11:40:41 PM Well done.+1 2008-09-18 11:47:23 PM +14 2008-09-18 11:47:31 PM awesome//I don't get it 2008-09-18 11:49:13 PM Just remember, the faster you get it off, the less it hurts. 2008-09-18 11:50:46 PM gause he's gonna need it.../good one Mr. subby 2008-09-18 11:51:57 PM +ELEVENTY!!...

+Vote!
+Vote!

Experimental psoriasis drug beats Enbrel in study

In an unusual head-to-head study, researchers for Johnson & Johnson's Centocor announced that their experimental therapy for psoriasis outperformed the leading biologic therapy in eliminating red, scaly skin patches. Data from the late-stage study demonstrated that ustekinumab reduced the patches by at least three quarters among 74 percent of patients in the 90 mg dose group and 68 percent in the...